Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed.
Megan I Mitchell, Iddo Z Ben-Dov, Kenny Ye...
https://pubmed.ncbi.nlm.nih.gov/38659349Actively Recruiting
Led by Albert Einstein College of Medicine · Updated on 2026-01-13
2000
Participants Needed
1
Research Sites
N/A
Total Duration
A
Albert Einstein College of Medicine
Lead Sponsor
N
National Center for Advancing Translational Sciences (NCATS)
Collaborating Sponsor
Researchers are investigating whether cough can serve as a non-invasive way to study the lungs for detecting large molecules like DNA and proteins. The study aims to develop and test a method that captures cough samples and isolates deep-lung specific extracellular vesicles (EVs), comparing these with invasive lung samples and mouth rinses from the same participants. This approach could help in early detection and risk assessment of lung diseases including lung cancer, asthma, and COPD. The study collects cough samples using a handheld chamber device, instructing participants to cough every 30 seconds for 10 minutes. The collected specimens, along with mouth rinse and bronchoalveolar lavage samples, are analyzed for DNA mutations using advanced sequencing and for lung-specific proteins through proteomic techniques. The research includes healthy volunteers, smokers, and people living with HIV, with comparisons made across these groups. Participants provide samples during clinical visits and are followed for up to 3 months to collect diagnostic updates. Researchers perform detailed DNA mutation and protein analyses on the samples to evaluate how well cough specimens represent deep lung material. The study emphasizes non-invasive collection and aims to support future development of large-scale clinical and public health applications for lung disease diagnosis and monitoring.
CONDITIONS
Cough Capture as a Portal Into the Lung
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day (up to 30 minutes for collection of all airway samples)
Participants provide samples including cough, mouthrinse, and bronchoalveolar lavage (BAL) during bronchoscopy as part of routine care to measure DNA mutation and proteomic profiles.
1 visit (in-person)
Duration - 3 months
Participants are followed for 3 months through medical record review to gather updated diagnostics and clinical information.
No additional visits; data collection via medical record
Total: 1 location
1
Albert Einstein College of Medicine
The Bronx, New York, United States, 10461
Actively Recruiting
A
Aham Okorozo, MD
K
Khulan Batbayar, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Megan I Mitchell, Iddo Z Ben-Dov, Kenny Ye...
https://pubmed.ncbi.nlm.nih.gov/38659349Miao Shi, Weiguo Han, Olivier Loudig...
https://pubmed.ncbi.nlm.nih.gov/37095155Zhenqiu Huang, Shixiang Sun, Moonsook Lee...
https://pubmed.ncbi.nlm.nih.gov/35410377Olsida Zefi, Spencer Waldman, Ava Marsh...
https://pubmed.ncbi.nlm.nih.gov/39160511Batbayar Khulan, Kenny Ye, Miao Kevin Shi...
https://pubmed.ncbi.nlm.nih.gov/39980243